Cargando…
Modeling receptor flexibility in the structure-based design of KRAS(G12C) inhibitors
KRAS has long been referred to as an ‘undruggable’ target due to its high affinity for its cognate ligands (GDP and GTP) and its lack of readily exploited allosteric binding pockets. Recent progress in the development of covalent inhibitors of KRAS(G12C) has revealed that occupancy of an allosteric...
Autores principales: | Zhu, Kai, Li, Cui, Wu, Kingsley Y., Mohr, Christopher, Li, Xun, Lanman, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512760/ https://www.ncbi.nlm.nih.gov/pubmed/35930206 http://dx.doi.org/10.1007/s10822-022-00467-0 |
Ejemplares similares
-
Addressing
Atropisomerism in the Development of Sotorasib,
a Covalent Inhibitor of KRAS G12C: Structural, Analytical, and Synthetic
Considerations
por: Lanman, Brian A., et al.
Publicado: (2022) -
Mechanisms of Resistance to KRAS(G12C) Inhibitors
por: Dunnett-Kane, Victoria, et al.
Publicado: (2021) -
TEAD Inhibitors Sensitize KRAS(G12C) Inhibitors via Dual Cell Cycle Arrest in KRAS(G12C)-Mutant NSCLC
por: Tammaccaro, Salvina Laura, et al.
Publicado: (2023) -
The Research Progress of Direct KRAS G12C Mutation Inhibitors
por: Yang, Ai, et al.
Publicado: (2021) -
KRAS(G12C)-independent feedback activation of wild-type RAS constrains KRAS(G12C) inhibitor efficacy
por: Ryan, Meagan B., et al.
Publicado: (2022)